| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |